TAMU_3DRC

We provides access to state-of-the-art tools to support the discovery of new drugs and new treatments for devastating diseases of our time. RRID: SCR_022214

[TAMU_3DRC @TAMU_3DRC]

Our new SPR scientist Dr. Churion giving her insights of SPR in Real-World Drug Discovery @Cytiva Houston Biacore User Day at TMC

[Texas A&M IBT @TAMU_IBT]

Discover Texas A&M Health's impactful presence in the Medical Center! In our latest video, "Dr. Ramos on Texas A&M Health Institute of Biosciences and Technology’s Mission," our Executive Director shares our dedication to advancing health through groundbreaking research.

[TAMU_3DRC @TAMU_3DRC]

This little sweet instrument from @BDBiosciences will be house at our Core facility @TMC_HelixPark for the next 3 months. Contact us if you would like a demo .

[TAMU_3DRC @TAMU_3DRC]

Excited to celebrate another five years of our program funded by @CPRITTexas, https://t.co/DGj9GEOj4N

[TAMU_3DRC @TAMU_3DRC]

@ReidPowell66387 Day 2 : Showcase GCC cores @GCC_Research

[TAMU_3DRC @TAMU_3DRC]

@GCC_Research for #GCCIDDD25 conference with Dr. Powell participates in Panel session “ Preclinical to Clinical: Observed Translational Differences “

[TAMU_3DRC @TAMU_3DRC]

@ReidPowell66387

[TAMU_3DRC @TAMU_3DRC]

Wrapped up first day!!

[Gulf Coast Consortia - Research @GCC_Research]

Invitation: Neuroinflammation: Therapeutics and Infrastructure Workshop, May 20 - https://t.co/ji50htVtfE

[TAMU_3DRC @TAMU_3DRC]

Welcome Dr. Michaels Glassman, who recently joined our team from Ridgeline Therapeutics! Dr. Glassman is a medicinal and computational chemist with over 7 years of experience, specializing in retrosynthetic analysis, natural product synthesis, and reaction optimization.

[TAMU_3DRC @TAMU_3DRC]

Check out our new library github site where you can find and download information on our current libraries content. https://t.co/em6cjvzpKm

[TAMU_3DRC @TAMU_3DRC]

Another recognition from our Core, Dr. Powell, a recipient of 2024 Alkek Early Career Investigator Fellowship Award on his plan to adopt open-source AI-driven frameworks in Drug Discovery @TAMU_IBT

[TAMU_3DRC @TAMU_3DRC]

Congratulations to our Core Director, Dr. Clifford Stephan being named the winner of @TAMUmedicine 2024 Research Excellence Award for Research Scientist and Academic Professional Track Faculty. We couldn’t be so proud working under his leadership @TAMU_IBT

[TAMU_3DRC @TAMU_3DRC]

Second day @GCC_Research, #GCCIDDD2024, connect with us for your drug discovery and high throughput screening needs.

[TAMU_3DRC @TAMU_3DRC]

@theNASciences @MDAndersonNews Congratulations to our long time collaborator!

[National Academy of Sciences @theNASciences]

Congratulations Helen Piwnica-Worms of @MDAndersonNews, newly inducted #NASmember! #NAS161 #cancerresearch #oncology

[TAMU_3DRC @TAMU_3DRC]

Congratulations to our new collaborator!

[National Academy of Sciences @theNASciences]

Congratulations Richard Wood of @MDAndersonNews, newly inducted #NASmember! #NAS161 #cancerresearch #biochemistry #genetics

[TAMU_3DRC @TAMU_3DRC]

@theNASciences @Aiims1742 @MDAndersonNews Congratulations Dr. Wood! We are glad to start our collaboration .

[TAMU_3DRC @TAMU_3DRC]

3DRC Core Director of HtFCP , couldn’t have asked for for a better leadership.

[Texas A&M IBT @TAMU_IBT]

Dr. Margie Moczygemba’s Journey Balancing Science, Education, and Leadership https://t.co/whYvLsLTuq

[TAMU_3DRC @TAMU_3DRC]

Well, this is all we got @TMC_HelixPark , still an amazing sight with the eclipse glass,#Eclipse2024